Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) Short Interest Update

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) was the recipient of a large increase in short interest in the month of April. As of April 30th, there was short interest totaling 25,208 shares, an increase of 1,294.2% from the April 15th total of 1,808 shares. Based on an average daily volume of 10,871 shares, the short-interest ratio is currently 2.3 days.

Cardio Diagnostics Price Performance

Cardio Diagnostics stock remained flat at $0.01 during mid-day trading on Monday. 11,002 shares of the company’s stock were exchanged, compared to its average volume of 50,923. Cardio Diagnostics has a 12-month low of $0.01 and a 12-month high of $0.07. The stock’s 50 day simple moving average is $0.02 and its 200 day simple moving average is $0.02.

About Cardio Diagnostics

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc was founded in 2017 and is headquartered in Chicago, Illinois.